about
NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell deathPim1 kinase synergizes with c-MYC to induce advanced prostate carcinomaDisease progression mediated by egr-1 associated signaling in response to oxidative stressGenetically engineered mouse models of prostate cancerRUNX3, EGR1 and SOX9B form a regulatory cascade required to modulate BMP-signaling during cranial cartilage development in zebrafishConditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasiaHepatic gene expression profiling of 5'-AMP-induced hypometabolism in miceQuantitative monitoring of mouse lung tumors by magnetic resonance imaging.Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.Differential regulation of NAB corepressor genes in Schwann cells.A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells.Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancerHigh frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers.A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells.NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex.Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancerEgr-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1/2 and JNK signaling pathwaysEarly growth response 1 protein, an upstream gatekeeper of the p53 tumor suppressor, controls replicative senescenceSuppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cellsCell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival.WT1/EGR1-mediated control of STIM1 expression and function in cancer cellsA shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphomaPlasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signalingRegulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells.EGR1 regulates hepatic clock gene amplitude by activating Per1 transcription.The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke.Early growth response genes regulate B cell development, proliferation, and immune response.Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma AgonistsESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells.RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.Is EGR1 a potential target for prostate cancer therapy?
P2860
Q24336481-2D9DB7EA-B0CC-4F46-97D9-46ECFFCC5C16Q24630639-86765F7B-56B6-462A-A7AA-9F609706B2BBQ27022982-3AF2EF94-44D2-44B1-8060-4D6128664362Q27026768-8BC09FD7-B1CC-4F9D-95EC-A9866C65348AQ27334714-3BC26EC1-B2FC-4690-9BB8-EE04672F1BFFQ28587079-ECD0ABBF-2F25-4A48-8482-0B5393D50990Q30500190-8F853AA8-AAE2-454D-9514-B4DD1943F294Q30560325-96C2A654-DCE3-4CFD-B2DF-252EFC9F2138Q30866782-8617F97C-B2B3-4AE9-B471-05C7DB26693BQ33311623-DD36C895-E5C5-45B7-BC7B-9AB0FD2D059EQ33348538-1DBF27FC-8668-4557-8F22-0E97B8E0B33CQ33352317-923B726A-B023-4114-8343-B80EEE033E26Q33514114-4B4FD395-E3CF-47B7-A6B7-CBDA08839F62Q33591747-B7BDFAA1-E9E5-4A21-A079-4F27AAE2D6E0Q33723716-DBD4283F-94B2-4ACF-8C12-4DBFE09059F9Q33898466-9C79496E-5639-41BC-8E28-5E6C3A91633EQ33936343-B4C20586-40C0-45F5-AF96-1B77E8CCA128Q34158621-D761222F-3307-4CBC-B904-DBBE43662FAFQ34507079-C7458414-19F7-4D6B-BC8C-2F0AED166257Q34559139-DA90B9DB-EB7B-4B4A-9102-CC06BC2337B9Q34690943-A1FA47E1-91F4-4FCE-9813-529A8C26D19BQ34867938-B864F67A-B935-49B1-9C8A-594DEEE40B61Q34876201-2301D920-8897-4EED-ADF8-E482D37236C2Q35168294-10708662-2ED1-4315-B5F5-475436C2751BQ35192595-8E6C8376-F6B1-4538-A41F-9319E2D4BE5DQ35575649-60C7F363-F688-4FB2-8EBF-7A015E375C14Q35631310-7C520E67-F473-47F5-9BCD-FB7E8F87E928Q35657424-7316624A-E2B0-45A8-9DF5-967ADBB8CF32Q35836030-EE1271A8-04C7-497D-9DD6-CB385FD72053Q35863768-268A7E54-0FAA-4740-8AF2-BC32FC504D49Q36078600-E511696D-F17A-4B68-8131-551022F76A4FQ36168199-91152B34-21EB-4DE5-840D-2EF1CE5B7A59Q36247095-3805ED1B-43E7-453C-83ED-727820081693Q36734866-EEA822E0-D877-4DDF-B99B-F5C116E73654Q36992618-DC0F191D-276A-4A61-8A91-CE11AE287860Q37077098-57CE1D6F-0221-4FC0-A353-826C5101FC4CQ37098082-24F7D7A3-E959-478A-B25A-75D98E76BBDEQ37149065-2D09C658-7E8E-4FB6-A5AD-97A2C4FA03BBQ37374251-038AB96A-8A17-4BC7-A5AE-A14A6423390FQ37418513-F941DC1D-486A-4C85-9296-A8E49F10BA7A
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Impaired prostate tumorigenesis in Egr1-deficient mice.
@ast
Impaired prostate tumorigenesis in Egr1-deficient mice.
@en
type
label
Impaired prostate tumorigenesis in Egr1-deficient mice.
@ast
Impaired prostate tumorigenesis in Egr1-deficient mice.
@en
prefLabel
Impaired prostate tumorigenesis in Egr1-deficient mice.
@ast
Impaired prostate tumorigenesis in Egr1-deficient mice.
@en
P2093
P356
P1433
P1476
Impaired prostate tumorigenesis in Egr1-deficient mice.
@en
P2093
Abdulkadir SA
Ackerman JJ
Carbone JM
Catalona WJ
Garabedian E
Humphrey PA
Milbrandt J
Naughton CK
P2888
P304
P356
10.1038/83231
P407
P577
2001-01-01T00:00:00Z
P6179
1021772044